Plain-English translation of NCT05786196 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two different surgical approaches to treating open-angle glaucoma—a condition where increased eye pressure gradually damages the optic nerve. Both approaches use minimally invasive techniques that work by opening up the eye's natural drainage canal to help fluid flow out more freely and reduce pressure. The study compares the iTrack Advance device with the OMNI Surgical System to see which approach works better for people with mild to moderate glaucoma.
Many people with glaucoma either can't tolerate eye drops or want to reduce the number of medications they take. This trial exists to find out whether these newer, gentler surgical techniques can effectively lower eye pressure as a standalone treatment—meaning without needing to combine them with other procedures.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive one of the two surgical techniques. The surgery itself is minimally invasive and performed as an outpatient procedure. You will have multiple follow-up visits after surgery where your eye pressure will be measured and your vision will be checked to see how well the treatment is working. The study will track your results over time to compare how effective each technique is.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Germany
Spain
United Kingdom